SPEAKER LIST

Edward Abrahams, Ph.D., Executive Director, Personalized Medicine Coalition
Gregory P. Adams, Ph.D., Co-Leader, Molecular and Translational Medicine Program, Fox Chase Cancer Center
Muhammad Al-Hajj, Ph.D., Group Leader, Pre-Clinical Oncology, AstraZeneca Biologics Unit, MedImmune, LLC.
Jonas S. Almeida, Ph.D., Abell-Hanger Distinguished Professor, Bioinformatics and Computational Biology, University of Texas, M.D. Anderson Cancer Center
Irina Antonijevic, M.D., Ph.D., Director, Translational Research, Biological Research, Lundbeck Research, Inc. USA
Michelle Arkin, Ph.D., Associate Director, Biology, Small Molecule Discovery Center, Pharmaceutical Chemistry, University of California, San Francisco
Ramy Arnaout, Beth Israel Deaconess Medical Center
Rebecca Ashfield, D.Phil., Senior Research Project Manager, Immunocore Ltd.
Patrick Baeuerle, Ph.D., Chief Scientific Officer and Senior Vice President, Research & Development, Micromet AG
Jack Ballantyne, Ph.D., Professor, Department of Chemistry, Associate Director for Research, National Center for Forensic Science, University of Central Florida
Gang Bao, Ph.D., Professor, Department of Biomedical Engineering, Georgia Institute of Technology and Emory University
Jeffrey S. Barrett, Ph.D., FCP, Pediatrics Director, Pediatric Pharmacology Research Unit, The Children’s Hospital of Philadelphia
Damien Bates, M.D., Ph.D., Chief Medical Officer, Organogenesis, Inc.
Roderick L. Beijersbergen, Ph.D., Group Leader, Division of Molecular Carcinogenesis, The Netherlands Cancer Institute
Dennis Benjamin, Ph.D., Senior Director, Antibody Technologies, Seattle Genetics, Inc.
Donald Bergstrom, Ph.D., Director, Experimental Medicine Oncology, Merck
Harold S. Bernstein, M.D., Ph.D., Professor of Pediatrics, Eli and Edythe Broad Center of Regeneration Medicine & StemCell Research, University of California, San Francisco Cardiovascular Research Institute
Brian S. J. Blagg, Ph.D., Associate Professor of Medicinal Chemistry, The University of Kansas; Winner of the 2009 David W. Robertson Award in Medicinal Chemistry
David Blakey, Ph.D., Chief Scientist, Cancer and Infection Research Area, AstraZeneca
Mark N. Blatt, M.D., MBA, Director, Healthcare Industry Solutions, Digital Health Group, Intel Corporation
Josip Blonder, M.D., Senior Research Scientist; Head, Quantitative Proteomics, NCI Frederick
David Blumenthal, M.D., M.P.P., National Coordinator, Health Information Technology (invited)
Mike Boswood, President and Chief Executive Officer, Thomsom Reuters
David J. Brailer, M.D., Ph.D., Chairman, Health Evolution Partners
Markus Bredel, M.D., Ph.D., Director, Northwestern Brain Tumor Institute Research Program, Assistant Professor, Department of Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, and Lurie Center for Cancer Genetics Research and Center for Genetic Medicine
Bob D. Brown, Ph.D., Senior Vice President, Research, Dicerna Pharmaceuticals Corp.
Frank Brown, Ph.D., Vice President & Chief Scientific Officer, Accelrys
Rob Brown, Ph.D., Senior Director, Informatics Marketing, Accelrys
Kenneth H. Buetow, Ph.D., Associate Director, Bioinformatics and Information Technology, National Cancer Institute
Barry A. Bunin, Ph.D., Chief Executive Officer & President, Collaborative Drug Discovery (CDD), Inc.
Matthew Burger, Ph.D., Research Investigator II, Global Discovery Chemistry, Novartis Institutes for Biomedical Research
Phil Burton, Ph.D., Chief Executive Officer & Chief Scientific Officer, ADMETRx, Inc.
Charles R. Cantor, Ph.D., Chief Scientific Officer, Sequenom, Inc.
Steven A. Carr, Ph.D., Director, Proteomics, The Broad Institute of MIT and Harvard
Nicholas Carruthers, Ph.D., Senior Research Fellow, Drug Discovery, Team Leader, Neuroscience, Johnson & Johnson Pharmaceutical R&D
Samuel Chackalamannil, Ph.D., Distinguished Research Fellow, Discovery Research, Schering-Plough Research Institute
Jake Chen, Ph.D., Assistant Professor, Informatics & Computer Science, Indiana University School of Informatics; Director, Indiana Center for Systems Biology and Personalized Medicine, Indiana University - Purdue University Indianapolis; Founder, MedeoLinx, Inc.
Randal Chen, Ph.D., Director, Research Informatics, Amgen, South San Francisco
Geoffrey Childs, Ph.D., Professor of Pathology, Albert Einstein College of Medicine
Jim Chinitz, Chief Executive Officer, Population Diagnostics, Inc.
Dalia Cohen, Ph.D., Chief Scientific Officer, Rosetta Genomics, Inc.
Tracey Colpitts, Ph.D., Manager, Abbott Molecular
Bruce Conklin, M.D., Senior Investigator, Gladstone Institute of Cardiovascular Disease, Professor of Medicine, Division of Medical Genetics, University of California, San Francisco
Christina M. Coughlin, M.D., Ph.D., Medical Director, Oncology Clinical Research and Development, Wyeth Research
Carlo M. Croce, M.D., Professor, Internal Medicine, College of Medicine & Public Health, The Ohio State University
John F. Crowley, Founder, Novazyme Pharmaceuticals, Inc.
Tapas K. Das Gupta, M.D., Ph.D., D.Sc., Professor and Head, Surgical Oncology, University of Illinois Chicago; Co-founder, CDG Therapeutics, Inc.
Giles M. Day, Senior Director, BBC Informatics, Pfizer, Inc.
Francisco M. De La Vega, D.Sc., Distinguished Scientific Fellow, Computational Genomics Research, Genetics Systems R&D, Life Technologies
Teresa M. Deluca, M.D., M.B.A., Vice President, Personalized Medicine-Business Solutions, Medco Health Solutions, Inc.
John R. Desjarlais, Ph.D., Vice President, Research, Xencor, Inc.
Richard Ding, Chief Executive Officer, bioTheranostics, a bioMerieux Company
Sheng Ding, Ph.D., Assistant Professor, Chemistry, Scripps Research Institute
Hakim Djaballah, Ph.D., Director, HTS Core Facility, Memorial Sloan Kettering Cancer Center
Steven F. Dowdy, Ph.D., Investigator, Howard Hughes Medical Institute; Professor, Department of Cellular & Molecular Medicine, University of California, San Diego School of Medicine
Nicholas C. Dracopoli, Ph.D., Vice Presdient, Biomarkers, Centocor R&D, Inc., Johnson & Johnson
Stefan Dübel, Ph.D., Director, Biotechnology, Technische Universität Braunschweig, Germany
Martin Dym, Ph.D., Professor, Biochemistry & Molecular & Cellular Biology, Georgetown University Medical Center
Christophe J. Echeverri, Ph.D., Chief Executive Officer & Chief Scientific Officer, Cenix BioScience GmbH
Agamemnon Epenetos, Ph.D., FRCP, Chairman, Trojantec Ltd.
Daniel A. Erlanson, Ph.D., Co-founder, Carmot Therapeutics, Inc.
Henry A. Erlich, Ph.D., Vice President, Discovery Research, Human Genetics, Roche Molecular Systems, Inc.
John C.L. Erve, Ph.D., DABT, Principal Research Scientist II, Drug Safety Metabolism, Wyeth Research
Laura J. Esserman, Professor, Surgery, University of California, San Francisco Medical Center
Giora Z. Feuerstein, M.D., Assistant Vice President and Head, Discovery Translational Medicine, Wyeth Research Labs
Joanna Fowler, Ph.D., Senior Chemist, Brookhaven National Laboratory
Johannes Fruehauf, M.D., Ph.D., Vice President, Research, Cequent Pharmaceuticals, Inc.
Eric Furfine, Ph.D., Senior Vice President, Research & Pre-clinical Development, Adnexus Therapeutics, a Bristol-Myers Squibb R&D Company
Changshou Gao, Ph.D., Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune LLC.
Hans-Peter Gerber, Ph.D., Senior Director, Tumor Therapies, Wyeth Oncology Discovery
Gad Getz, Ph.D., Head, Cancer Genome Analysis, The Broad Institute
Paloma H. Giangrande, Ph.D., Assistant Professor, Department of Internal Medicine, University of Iowa
Klaus Giese, Ph.D., Chief Scientific Officer, Silence Therapeutics plc
Gary Gintant, Ph.D., Senior Group Leader, Department of Integrative Pharmacology, Abbott Laboratories
Stanley Gloss, Founding Partner & Managing Director, BioTeam, Inc.
Jorge Goldstein, Director, Biotechnology & Chemical Group, Sterne Kessler Goldstein Fox PLLC
Vera Gorfinkel, Ph.D., Associate Professor, Stony Brook University
Sarah Grimwood, Ph.D., Group Lead, Neuroscience Translational Biomarkers, Pfizer
Preethi H. Gunaratne, Ph.D., Assistant Professor, Department of Biology & Biochemistry, University of Houston
Austin Gurney, Ph.D., Vice President, Molecular and Cellular Biology, OncoMed Pharmaceuticals, Inc.
Steven I. Gutman, M.D., Professor, Pathology, University of Central Florida
Juergen Hammer, Ph.D., M.B.A., Pharma Research Scientific Informatics; Global Head, In Silico Sciences; Center Head, Scientific Informatics, F. Hoffmann-La Roche, Inc.
Lori Harmon, Manager, Drug Discovery Project Support and Laboratory Automation, Merck
David Haussler, Ph.D., Professor & Director, Biomolecular Science & Engineering, University of California, Santa Cruz
Michael Hennig, Ph.D., Vice Director & Head, Discovery Technologies, F. Hoffmann-La Roche Ltd
Steven Highlander, Ph.D., Partner, Intellectual Property, Fulbright & Jaworski, L.L.P.
Thomas P. Hill, Principal, The Leverage Innovation Group; former Director, Learning and Knowledge Management, Genentech
David Hodgson, Ph.D., Site Head, Global Research Informatics, Roche Palo Alto
René M.A. Hoet, Ph.D., Senior Director, Research, Genmab B.V.
Tim Hoey, Ph.D., Vice President, Cancer Biology, OncoMed Pharmaceuticals, Inc.
Thomas Högberg, Ph.D., Vice President, 7TM Pharma, Hørsholm, Denmark
Scott B. Hoyt, Ph.D., Research Fellow, Department of Basic Chemistry, Merck Research Laboratories
Pearl S. Huang, Ph.D., Integrator, Oncology Franchise, Research & Early Development, Merck & Co.
Alexandra Huhalov, Ph.D., Principal Scientist, Merrimack Pharmaceuticals
Dana Hu-Lowe, Ph.D., Group Leader, Associate Research Fellow, Cancer Biology, Pfizer, Inc., PGRD-La Jolla
Thomas Ichim, Ph.D., Chief Executive Officer, MediStem Labs, Inc.
Juan Carlos Izpisua Belmonte, Ph.D., Professor, Gene Expression Laboratory, Salk Institute for Biological Studies
Erica L. Jackson, Ph.D., Scientist, Department of Tumor Biology and Angiogenesis, Genentech, Inc.
Kewal K. Jain, M.D., Professor, Chief Executive Officer, Jain PharmaBiotech
Vivek Kadambi, Ph.D., Senior Director, Drug Safety Evaluation, Millenium Pharmaceuticals, The Takeda Oncology Company
Timothy J. Kamp, M.D., Ph.D., Professor of Medicine & Physiology; Co-Director Stem Cell and Regenerative Medicine Center, University of Wisconsin
Tugrul Kararli, Ph.D., President & Founder, Pharmacircle
Paul Kassner, Ph.D., Scientific Director, Lead Discovery, Amgen, Inc.
Karen L. Kaul, M.D., Ph.D., Board of Directors Chair of Molecular Pathology, Director, Molecular Diagnostics Division; Director, Pathology Residency Program, NorthShore University HealthSystem; Professor of Pathology and Urology, Northwestern University Medical School
Jeffery W. Kelly, Ph.D., Chair, Molecular and Experimental Medicine, Lita Annenberg Hazen Professor of Chemistry, The Skaggs Institute, The Scripps Research Institute
Edward Kesicki, Ph.D., Director, Small Molecule Drug Discovery, Infectious Disease Research Institute
Lise Kjems, M.D., Ph.D., Senior Director, Translational Medicine, Novartis Institute of Biological Research
Michael Koehler, Ph.D., Scientist, Discovery Chemistry, Genentech, Inc.
Andrei Konradi, Ph.D., Senior Director, Medicinal Chemistry, Elan Pharmaceuticals
Chandan Kumar, Ph.D., Michigan Center for Translational Pathology, University of Michigan
Raul Lacson, Ph.D., Senior Research Associate, Automated Biotechnology, Merck & Co.
Myla Lai-Goldman, M.D., Chief Executive Officer, CancerGuideDx
Michael Lajiness, Ph.D., Research Scientist, Structural and Computational Sciences, Eli Lilly & Company
Lisa LaLuna, Senior Vice President, Corporate Development & Implementation, ePharmaSolutions
John M. Lambert, Ph.D., Executive Vice President and Chief Scientific Officer, ImmunoGen, Inc.
Steve Langston, Ph.D., Senior Scientist, Millennium Pharmaceuticals, the Takeda Oncology Company
Megan Laurance, Ph.D., Senior Scientist, Ingenuity Systems, Inc.
Man-Ling Lee, Ph.D., Senior Program Analyst, Discovery Chemistry, Small Molecule Drug Discovery, Genentech, Inc.
Kevin G. Leong, Ph.D., Scientist, Tumor Biology and Angiogenesis, Genentech, Inc.
David S. Lester, Ph.D., Vice President, Human Health Solutions, Theranos
Alan Lewis, Ph.D., President & Chief Executive Officer, Juvenile Diabetes Research Foundation
Michael Liebman, Ph.D., Managing Director, Strategic Medicine, Inc.
Xiaoyu Lin, Ph.D., Associate Research Investigator, siRNA Therapeutics, Abbott Laboratories
Christine Loehrlein, Ph.D., A.D., New Products and Technology Strategy Research, Nektar Therapeutics
Nils Lonberg, Ph.D., Senior Vice President and Scientific Director, Medarex, Inc.
Jonathan Lord, Chief Executive Officer, Navigenics
William Lowry, Ph.D., Assistant Professor, Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles
Jennifer Lu, Ph.D., Professor, School of Engineering, University of California, Merced
Philip C.M. Ma, Ph.D., Director, McKinsey & Company, Inc.
Ian MacLachlan, Ph.D., Chief Scientific Officer, Tekmira Pharmaceuticals
Ravi Majeti, M.D., Ph.D., Assistant Professor, Division of Hematology, Stanford Cancer Center, Institute for Stem Cell Biology and Regenerative Medicine
Karen P. Mann, M.D., Ph.D., Associate Professor and Director, Molecular Hematopathology, Department of Pathology and Laboratory Medicine, Emory University Hospital; President Elect, Association of Molecular Pathology
Elizabeth Mansfield, Ph.D., Senior Genomics Advisor, Office of the Chief Scientist; Director, Personalized Medicine, Office of in Vitro Diagnostic Device Evaluation and Safety, Food & Drug Administration
Francesco Marincola, M.D., Chief, Infectious Disease and Immunogenetics Section, NIH; Editor in Chief, Journal of Translational Medicine
Jennie P. Mather, Ph.D., Senior Vice President, Stem Cell Research, MacroGenics, Inc.
Neil Matsui, Founder, Vice President, Research & Development, TRF Pharma (invited)
William B. Mattes, Ph.D., DABT, Former Executive Director, Predictive Safety Testing Consortium, Critical Path Institute
Ray Mattingly, Ph.D., Associate Professor, Pharmacology, Wayne State University
John F. McDonald, Professor and Director, Integrated Cancer Research Center, School of Biology, Georgia Institute of Technology
Joseph D. Miller, Ph.D., Chief, Laboratory Preparedness Officer, Influenza Division, Centers for Disease Control and Prevention
Christopher Miller, Ph.D., Group Director, Applied Genomics, Bristol-Myers Squibb Co.
Jeffrey D. Miller
Prasun J. Mishra, Ph.D., Laboratory of Cancer Biology & Genetics, National Cancer Institute, NIH
Uwe R. Müller, Ph.D., Vice President, Product Development, Banyan Biomarkers, Inc.
Joseph R. Nevins, Ph.D., Barbara Levine Professor, Breast Cancer Genomics, Center for Applied Genomics & Technology, Duke University
Pauline Ng, Ph.D., Senior Scientist, Human Genomic Medicine, J. Craig Venter Institute
Shuming Nie, Ph.D., Wallace H. Coulter Distinguished Faculty Chair in Biomedical Engineering, Director of Emory-Georgia Tech Cancer Nanotechnology Center, Professor of BME Chemistry, Materials Science and Engineering, and Hematology and Oncology, Emory University and Georgia Institute of Technology
Yuri Nikolsky, Ph.D., Chief Executive Officer, GeneGo, Inc.
N. R. Nirmala, Ph.D., Director, Biomarker Analysis and Informatics Unit, Translational Sciences, Novartis Institutes of Biomedical Research
Michael Nohaile, Ph.D., Head, Molecular Diagnostics, Novartis International AG
Jennifer Ohayon, Ph.D., BioDiscovery Project Leader, NanoInk, Inc.
Henrik Orum, M.Sc., Ph.D., Vice President & Chief Scientific Officer, Santaris Pharma
Jeremy Packer, Ph.D., Head, Bioinformatics, Abbott
Dan Peer, Ph.D., Head, Laboratory of Nanomedicine, Department of Cell Research and Immunology and the Center for Nanoscience and Nanotechnology, Tel Aviv University
Lance R. Peterson, M.D., FASCP, FIDSA, Director, Microbiology & Infectious Disease, Evanston Hospital, NorthShore University HealthSystem and University of Chicago
Richard G. Peterson, Ph.D., Executive Vice President, Research & Development, PreClinOmics, Inc.
German Pihan, M.D., Department of Pathology, Beth Israel Deaconess Medical Center
Wilhelm Pluester, Ph.D., Chief Executive Officer, Eppendorf Array Technologies S.A.
Franklyn G. Prendergast, M.D., Ph.D., Professor, Pharmacology, Biochemistry & Molecular Biology, Director, Center for Personalized Medicine, Mayo Clinic
April Pyle, Ph.D., Assistant Professor, Microbiology, Immunology & Molecular Genetics, Eli and Edythe Broad Center of Regenerative Medicine & Stem Cell Research; Jonsson Comprehensive Cancer Center, University of California, Los Angeles
Mika Rämet, M.D., Ph.D., Professor of Experimental Pediatric Immunology and Infectious Diseases, University of Tampere, Finland
Savithri Ramurthy, Ph.D., Research Investigator, GDC/ONC, Novartis Institutes of Biomedical Research, Emeryville, CA
Adam Renslo, Ph.D., Associate Director, Chemistry, Adjunct Assistant Professor, Pharmaceutical Chemistry
John Reynders, Ph.D., Chief Informatics Officer, Pharmaceutical Research & Development, Johnson & Johnson
Charles Reynolds, Ph.D., Research Fellow, Computer Aided Drug Discovery, Johnson & Johnson
Jeremy N. Rich, M.D., Chairman, Department of Stem Cell Biology and Regenerative Medicine, Cleveland Clinic
Angie Rizzino, Ph.D., Professor, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center
Matthew K. Robinson, Ph.D., Assistant Professor, Molecular and Translational Medicine Program, Fox Chase Cancer Center
John Rossi, Ph.D., Professor and Chair, Molecular Biology, Beckman Research Institute of the City of Hope
Lee Rubin, Ph.D., Director, Translational Medicine, Harvard Stem Cell Institute
Dmitry Samarsky, Ph.D., Vice President, Technology Development, RXi Pharmaceuticals
C. Satishchandran, Ph.D., Chief Technology Officer, Research Technology Center, Pfizer, Inc.
Kenneth A. Savin, Ph.D., Manager, Global External Research & Development, Eli Lilly & Co.
Eric Schadt, Ph.D., Senior Vice President, Sage BioNetworks
Faye D. Schilkey, Associate Director, N.M. Sequencing Center, National Center for Genome Resources
Uli Schmitz, Ph.D., Director, Structural Chemistry, Gilead
Paul J.H. Schoemaker, Ph.D., M.B.A., Chairman and Chief Executive Officer, Decision Strategies International, Inc.; Research Director, Mack Center for Technological Innovation, The Wharton School; Adjunct Professor of Marketing, The Wharton School Adjunct Professor, Wharton School of Business
Michael Schuster, M.S., M.B.A., Vice President, Operations, Angioblast Systems, Inc.
David M. Sedlock, Ph.D., Senior Director, Research & Development Systems, Millennium, The Takeda Oncology Company
Diane Seimetz, Ph.D., M.D.R.A., Chief Scientific Officer & Executive Vice President, Fresenius Biotech GmbH
Graeme Semple, Ph.D., Vice President, Discovery Chemistry, Arena Pharmaceuticals, Inc.
Christopher L. Shaffer, Ph.D., Associate Research Fellow, Pharmacokinetics, Dynamics & Metabolism, Pfizer, Inc.
Ajay Shah, Ph.D., MBA, PMP, Director, Research Informatics, Elan Pharmaceuticals, Inc.
Hing Sham, Ph.D., Senior Vice President, Chemical Sciences, Elan Pharmaceuticals, Inc.
Dan Shoemaker, Chief Technology Officer, Fate Therapeutics
Matt Silva, Head, Imaging Sciences, Millennium, The Takeda Oncology Company
Renato Skerlj, Ph.D., Vice President, Medicinal Chemistry, Genzyme Corporation Drug and Biomaterial R&D
Gary W. Small, M.D., Parlow-Solomon Professor on Aging, Professor of Psychiatry & Biobehavioral Sciences, Director, UCLA Center on Aging, Director, Memory & Aging Research Center, Director, Geriatric Psychiatry Division, Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at UCLA
Richard V. Smith, M.D., FACS, Professor and Vice Chair, Department of Otorhinolaryngology-Head and Neck Surgery, Montefiore Medical Center and Albert Einstein College of Medicine
Brian Smith, Ph.D., Director, Medicinal Chemistry, Arena Pharmaceuticals, Inc.
Douglas Spracklin, Ph.D., Director, Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc.
Arun Sreekumar, Ph.D., Molecular Oncology Program, Genomics/Epigenomics, Medical College of Georgia
Clive Stanway, Ph.D., Chief Scientific Officer, Cancer Research Technology Ltd., Wolfson Institute for Biomedical Research
Susie Stephens, Director, Biomedical Informatics, Pharmaceutical Research & Development, Johnson & Johnson
Robert L. Strausberg, Ph.D., Deputy Director, J. Craig Venter Institute
Alain Stricker-Krongrad, Ph.D., Senior Scientific Adviser, Global Business Development, Charles River
David Sugarbaker, M.D., Chief, Thoracic Surgery, Brigham and Women’s Hospital
Clive N. Svendsen, Ph.D., Professor, Anatomy & Neurology, University of Wisconsin
Nick Terrett, Ph.D., Chief Scientific Officer, Ensemble Discovery Corp.
Patrick F. Terry, Chief Executive Officer, Technic Solutions, LLC; Acting CEO, Grand Therapeutics, Inc.
Sharon Terry, M.A., President and Chief Executive Officer, Genetic Alliance
Helmut Thomas, Ph.D., Senior Vice President, Research & Preclinical Development, Tranzyme Pharma, Inc.
Frances Toneguzzo, Ph.D., Director, Office of Corporate Sponsored Research and Licensing, Massachusetts General Hospital
Alan Trounson, Ph.D., President, California Institute of Regenerative Medicine
Marc A. Unger, Ph.D., Chief Scientific Officer, Fluidigm Corporation
Peter J. van der Spek, Ph.D., Department of Bioinformatics, Erasmus MC - Medical Faculty
Laura Vantveer, Visiting Professor from the Netherlands (invited)
Gauri Varadhachary, M.D., Associate Professor of Medicine, Department of G.I. Medical Oncology, M.D. Anderson Cancer Center
Jean-Michel Vernier, Ph.D., Vice President, Chemistry Discovery, Ardea Biosciences
Karl Voelkerding, Ph.D., Associate Professor and Medical Director for Advanced Technology, Department of Pathology, ARUP Laboratories, University of Utah
Travis T. Wager, Ph.D. Associate Research Fellow, Neuroscience Discovery, Medicinal Chemistry, Pfizer, Inc.
Yuet Wai Kan, M.D., Professor, Genetics, University of California, San Francisco
Chris Waller, Ph.D., Senior Director, Precompetitive Collaborations, Research, Development & Medical Informatics, Worldwide Technology, Pfizer, Inc.
W. Patrick Walters, Ph.D., Senior Research Fellow & Group Head, Computational Drug Discovery Technologies, Vertex Pharmaceuticals, Inc.
Jingsong Wang, M.D., Director, Immunology, Discovery Medicine & Clinical Pharmacology, Bristol-Myers Squibb, Co.
Joseph A. Ware, Ph.D., Senior Scientist, Clinical Pharmacokinetics and Pharmacodynamics, Development Sciences, Genentech, Inc.
James W. Watters, Ph.D., Associate Director, Molecular Profiling Oncology, Merck
Joanne B. Weidhaas, Ph.D., Assistant Professor, Therapeutic Radiology, Yale University
Michael J. Werner, J.D., Partner, Holland & Knight (tentative)
David White, Ph.D., Vice President, Discovery Technologies, Agios Pharmaceuticals
Hans Winkler, Ph.D., Senior Director, Global Head Oncology Biomarkers, Johnson & Johnson
Edward Wirth III, M.D., Ph.D., Medical Director, Geron Corporation
K. Dane Wittrup, Ph.D., C.P. Dubbs Professor, Chemical Engineering & Biological Engineering, Associate Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Anna M. Wu, Ph.D., Professor, David Geffen School of Medicine at University of California, Los Angeles
Min Wu, Ph.D., Principal Scientist, Translational Research, AVEO Pharmaceuticals, Inc.
Jianfeng Xu, M.D., Ph.D., Professor, Epidemiology, Prevention and Cancer Biology, Director, Center for Cancer Genomics, Wake Forest University School of Medicine
Frederic S. Young, Ph.D., Chief Scientist, Vicus Therapeutics